Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N/A
R. ornithinolytica (formerly known as Klebsiella ornithinolytica) is a Gram-negative aerobic bacillus which belongs to the family Enterobacteriaceae. R. ornithinolytica B6 can be grown using glycerol, hexoses (glucose, fructose, galactose), pentose (xylose), or disaccharide (sucrose) as a sole carbon source. When sugars are supplied, the main product of the bacterium is 2,3-butanediol, even at a relatively low temperature (25��C). Hence, R. ornithinolytica B6 has energy-saving advantages for industrial production of 2,3-butanediol. 2,3-Butanediol is a very useful chemical, which is used as a solvent and as a precursor to various chemicals and synthetic polymers (1, 2). A 2,3-butanediol-producing bacterium, strain B6, was isolated from an oil-contaminated soil sample collected from the Backwoon Mountain in South Korea for screening of organic compound-tolerant bacteria. Studies have shown that acetoin production increases rapidly in stationary phase in producing 2,3-butanediol. Also through transcriptome analysis, we found that the expression level of acetoin reductase increased sharply after 2,3-butanediol production. In producing 2,3-butanediol, it is necessary to block the route of succinic acid, lactic acid, and fumaric acid, as well as inactivate acetoin reductase. [PMID: 23814034]
Raoultella ornithinolytica is an encapsulated Gram-negative aerobic bacillus belonging to the Enterobacteriaceae family. Formerly known as Klebsiella ornithinolytica , the bacterium was reclassified as Raoultella based on new genetic approaches. 1 R. ornithinolytica is known to inhabit aquatic environments and can be found in hospital environments. 2 The pathogenic potential of R. ornithinolytica isolates in human disease has become increasingly important. Many cases of biliary tract infection, urinary infection, and bacteraemia caused by R. ornithinolytica have been reported. [PMID: 26921549]
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces (Alkhalil2017 - can be high load in ulcerative colitis patients), clinical sources (throat, urine) and food
DNA G+C(%): 57
|
Low T(℃): 4(+)
High T(℃): 42(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: Var(MIC50): 4, MIC90: 16, RNG: (1->32)
ampicillin: R(vr)
carbenicil: Res
penicillin: Res
piper-taz: Var(MIC50): 2, MIC90: 8, RNG: (≤0.12->256)
ticarcillin: Res
ertapenem: S(MIC50): 0.008, MIC90: 0.03, RNG: (≤0.008->16)
imipenem: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.06->16)
|
cefepime: S(MIC50): 0.12, MIC90: 0.25, RNG: (≤0.12->16)
ceftazidime: Var(MIC50): >2, MIC90: >16, RNG: (≤2->16)
|
amikacin: S(MIC50): 1, MIC90: 2, RNG: (≤0.25->32)
gentamicin: S(MIC50): ≤2, MIC90: ≤2, RNG: (≤2->16)
kanamycin: Sens
streptomycin: Sens
|
azithromycin: S(MIC50): 0.12, MIC90: 0.5, RNG: (≤0.12->16)
|
ciprofloxacin: S(MIC50): 0.06, MIC90: 0.5, RNG: (≤0.016->4)
gatifloxacin: S(MIC50): 0.06, MIC90: 0.5, RNG: (≤0.03->4)
nalidixic-acid: Sens
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: Var(MIC50): >2, MIC90: >8, RNG: (≤2->8)
tigecycline: S(MIC50): 0.5, MIC90: 1, RNG: (0.12-4)
|
|
|
chloramphenicol: Sens
sulfadiazine: Sens
|
colistin: Sens
|